Amalgamated Bank Bluebird Bio, Inc. Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 6,510 shares of BLUE stock, worth $53,967. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,510

Previous 6,510 -0.0%

Holding current value

$53,967

Previous $6,000 50.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$0.91 - $1.75 $2,283 - $4,390	-2,509 Reduced 27.82%	6,510 $8,000
Q4 2023 Feb 06, 2024	SELL	$1.32 - $4.83 $1,177 - $4,308	-892 Reduced 9.0%	9,019 $12,000
Q1 2023 May 02, 2023	SELL	$3.14 - $8.22 $3,152 - $8,252	-1,004 Reduced 9.2%	9,911 $32,000
Q4 2022 Feb 10, 2023	BUY	$5.77 - $8.49 $8,649 - $12,726	1,499 Added 15.92%	10,915 $76,000
Q3 2022 Nov 09, 2022	BUY	$3.75 - $7.39 $2,096 - $4,131	559 Added 6.31%	9,416 $60,000
Q2 2022 Aug 15, 2022	BUY	$2.94 - $5.23 $2,131 - $3,791	725 Added 8.92%	8,857 $37,000
Q1 2022 Jun 30, 2022	BUY	$4.07 - $10.6 $33,097 - $86,199	8,132 New	8,132 $39,000
Q3 2021 Oct 29, 2021	SELL	$11.24 - $21.0 $106,633 - $199,227	-9,487 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$18.04 - $22.09 $6,223 - $7,621	-345 Reduced 3.51%	9,487 $303,000
Q1 2021 May 13, 2021	SELL	$16.59 - $33.89 $11,596 - $23,689	-699 Reduced 6.64%	9,832 $296,000
Q4 2020 Feb 12, 2021	SELL	$27.5 - $37.92 $302 - $417	-11 Reduced 0.1%	10,531 $295,000
Q3 2020 Oct 30, 2020	BUY	$34.44 - $43.75 $3,306 - $4,200	96 Added 0.92%	10,542 $569,000
Q2 2020 Aug 10, 2020	SELL	$27.12 - $45.97 $42,795 - $72,540	-1,578 Reduced 13.12%	10,446 $638,000
Q1 2020 May 13, 2020	SELL	$26.16 - $63.5 $9,103 - $22,098	-348 Reduced 2.81%	12,024 $553,000
Q4 2019 Feb 13, 2020	BUY	$46.96 - $61.67 $69,641 - $91,456	1,483 Added 13.62%	12,372 $1.09 Million
Q3 2019 Nov 13, 2019	SELL	$59.47 - $93.1 $8,979 - $14,058	-151 Reduced 1.37%	10,889 $1 Million
Q2 2019 Aug 14, 2019	SELL	$75.84 - $105.21 $51,798 - $71,858	-683 Reduced 5.83%	11,040 $1.4 Million
Q1 2019 May 15, 2019	BUY	$64.44 - $104.11 $14,821 - $23,945	230 Added 2.0%	11,723 $1.84 Million
Q4 2018 Feb 15, 2019	BUY	$59.1 - $93.26 $191,838 - $302,721	3,246 Added 39.36%	11,493 $1.14 Million
Q3 2018 Nov 14, 2018	SELL	$88.86 - $117.49 $246,408 - $325,799	-2,773 Reduced 25.16%	8,247 $1.2 Million
Q2 2018 Jul 18, 2018	BUY	$99.64 - $127.59 $451,767 - $578,493	4,534 Added 69.9%	11,020 $1.73 Million
Q1 2018 May 22, 2018	SELL	$105.8 - $150.94 $12,167 - $17,358	-115 Reduced 1.74%	6,486 $1.11 Million
Q4 2017 Feb 13, 2018	BUY	$81.25 - $130.7 $70,362 - $113,186	866 Added 15.1%	6,601 $1.18 Million
Q3 2017 Nov 09, 2017	BUY	$57.74 - $91.42 $331,138 - $524,293	5,735	5,735 $788,000

Others Institutions Holding BLUE

# of Institutions

147

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $639M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Bluebird Bio, Inc. Transaction History